Cargando…
Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496657/ https://www.ncbi.nlm.nih.gov/pubmed/33907908 http://dx.doi.org/10.1007/s10549-021-06223-6 |
| _version_ | 1784579799741628416 |
|---|---|
| author | Kazmi, Shayma Chatterjee, Debanjana Raju, Dheeraj Hauser, Rob Kaufman, Peter A. |
| author_facet | Kazmi, Shayma Chatterjee, Debanjana Raju, Dheeraj Hauser, Rob Kaufman, Peter A. |
| author_sort | Kazmi, Shayma |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8496657 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84966572021-10-19 Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine Kazmi, Shayma Chatterjee, Debanjana Raju, Dheeraj Hauser, Rob Kaufman, Peter A. Breast Cancer Res Treat Correction Springer US 2021-04-27 2021 /pmc/articles/PMC8496657/ /pubmed/33907908 http://dx.doi.org/10.1007/s10549-021-06223-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Kazmi, Shayma Chatterjee, Debanjana Raju, Dheeraj Hauser, Rob Kaufman, Peter A. Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine |
| title | Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine |
| title_full | Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine |
| title_fullStr | Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine |
| title_full_unstemmed | Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine |
| title_short | Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine |
| title_sort | correction to: overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496657/ https://www.ncbi.nlm.nih.gov/pubmed/33907908 http://dx.doi.org/10.1007/s10549-021-06223-6 |
| work_keys_str_mv | AT kazmishayma correctiontooverallsurvivalanalysisinpatientswithmetastaticbreastcancerandliverorlungmetastasestreatedwitheribulingemcitabineorcapecitabine AT chatterjeedebanjana correctiontooverallsurvivalanalysisinpatientswithmetastaticbreastcancerandliverorlungmetastasestreatedwitheribulingemcitabineorcapecitabine AT rajudheeraj correctiontooverallsurvivalanalysisinpatientswithmetastaticbreastcancerandliverorlungmetastasestreatedwitheribulingemcitabineorcapecitabine AT hauserrob correctiontooverallsurvivalanalysisinpatientswithmetastaticbreastcancerandliverorlungmetastasestreatedwitheribulingemcitabineorcapecitabine AT kaufmanpetera correctiontooverallsurvivalanalysisinpatientswithmetastaticbreastcancerandliverorlungmetastasestreatedwitheribulingemcitabineorcapecitabine |